Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Diet Suppl. 2008;5(3):248-63.

Pharmacokinetics of green tea catechins in extract and sustained-release preparations.

Author information

  • 1Botanical Center In Vivo Core, Purdue University, Department of Foods and Nutrition, West Lafayette, IN 47907, USA. janle@purdue.edu

Abstract

Catechins are a major constituent of green tea. For green tea to have cancer therapeutic benefit, catechin concentrations in the range of 100 nM are required continuously until apoptosis (programmed cell death) is induced. To prolong elevated plasma and interstitial concentrations of catechins, a sustained-release formulation of green tea extract was tested and compared to a commercial green tea extract (Tegreen97®). Sustained-release formulations are usually developed in the pharmaceutical industry to slowly deliver the compound over a period of time and increase the dosing interval. Plasma and interstitial fluid (ISF) pharmacokinetics of catechins were determined following an oral dose in the rat. The sustained-release formulation profile included multiple smaller peaks of total catechins in both plasma and ISF. Interstitial fluid profiles of green tea extract indicate that higher catechins concentration and longer duration in tissue than in blood may make a sustained-release form unnecessary.

KEYWORDS:

Green tea pharmacokinetics; sustained release

PMID:
19885387
[PubMed - indexed for MEDLINE]
PMCID:
PMC2747776
Free PMC Article

Images from this publication.See all images (3)Free text

FIGURE 1
FIGURE 2
FIGURE 3
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk